ArticleFrontiers in nutrition2025
Establishment of age-stratified serum vitamin B6 pyridoxal and pyridoxic acid reference intervals among children aged 1-16 years in Henan, china.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: The development of population-specific reference intervals (RIs) for serum vitamin B6 (B6) in Chinese pediatric populations has not been established. Current clinical practice relies on international thresholds, but diagnostic sensitivity with domestic biochemical profiles remains suboptimal. This study aims to establish age-stratified reference intervals for serum vitamin B6 pyridoxal (B6-PL) and pyridoxic acid (B6-PA) in Henan children aged 1-16 years. Methods: This retrospective study analyzed 1,458 healthy children undergoing routine physical examinations at Henan Children's Hospital from December 2021 to June 2024. Serum B6-PL and B6-PA were quantified using the Xevo TQ-S Micro liquid chromatography-tandem mass spectrometry system (Waters Corporation). Non-normally distributed data are expressed as median interquartile range (IQR) [M (P Results: Analysis revealed that age significantly influences serum levels of B6-PL and B6-PA in children, while gender showed no significant effect. The pediatric cohort demonstrated a male predominance (58.98%, 860/1458) with a notable prepubertal skew (93.28%, 1360/1458 aged < 12 years). Further analysis facilitated the establishment of RIs for B6-PL and B6-PA across different age groups. The RIs for B6-PL were 1.62-17.70 ng/mL for children aged 1-5 years, 1.39-15.15 ng/mL for children aged 6-11 years, and 1.06-14.30 ng/mL for children aged 12-16 years. The RIs for B6-PA were 1.20-5.46 ng/mL for children aged 1-5 years, 1.10-4.41 ng/mL for children aged 6-11 years, and 0.95-4.99 ng/mL for children aged 12-16 years. Conclusion: This study establishes the first age-stratified RIs for serum vitamin B6 metabolites (B6-PL and B6-PA) among children aged 1-16 years in Henan, China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.